Barr Laboratories, Inc. Third Quarter Fiscal 2003 Earnings Conference Call.Business Editors POMONA, N.Y.--(BUSINESS WIRE)--April 15, 2003 The management team of Barr Laboratories, Inc. (NYSE NYSE See: New York Stock Exchange : BRL BRL In currencies, this is the abbreviation for the Brazilian Real. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. ) invites you to participate in a conference call to discuss its financial results and performance highlights for the third quarter of fiscal 2003, ended March 31, 2003. Bruce Bruce, Scottish royal family descended from an 11th-century Norman duke, Robert de Brus. He aided William I in his conquest of England (1066) and was given lands in England. L. Downey, Chairman and Chief Executive Officer and Bill McKee, Senior Vice President, Treasurer and Chief Financial Officer, will discuss our results and respond to investor questions. The full release will be provided to you before the NYSE market opens on April 24. You may participate in this call by dialing 1-800- 230-1766 for domestic calls or 1-612-326-1004 for international calls and request the Barr Laboratories conference call. The live webcast of the conference call will be accessible through Barr Laboratories, Inc. website at www.barrlabs.com or at CCBN's individual investor center at www.companyboardroom.com. The webcast will be archived on both websites for future on- demand replay. If you have any questions regarding the call, please contact Carol A. Cox, Vice President Investor Relations Investor relations The process by which the corporation communicates with its investors. and Corporate Communications Corporate communications is the process of facilitating information and knowledge exchanges with internal and key external groups and individuals that have a direct relationship with an enterprise. at (845) 348- 6808. About Barr Laboratories Barr Laboratories, Inc. is a specialty pharmaceutical company engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion